Metabolic Disorders
Steering Committee

The Biomarkers Consortium’s Cancer, Inflammation and Immunity, Metabolic Disorders and Neuroscience Steering Committees are responsible for identifying and moving forward promising pre-competitive biomarkers projects for implementation by the Biomarkers Consortium, as well as overseeing each individual project under its purview. The members of each Steering Committee represent a variety of sectors, including academia, government, industry and not-for-profit/advocacy organizations, and are led by two co-chairs representing two of the following three sectors: academia, government or industry.

Henry Burch, M.D., NIH/NIDDK (Co-Chair)

Roberto Calle, M.D., Regeneron (Co-Chair)

Vandana Sachdev, M.D., NIH/NHLBI (Co-Chair)

Nigel Beaton, Ph.D., Biognosys

Stan Belkowski, Ph.D., Janssen

Javed Butler, MD, University of Mississippi

Joel Dalrymple, Ph.D., Somalogic

Samuel Engel, M.D., Merck

Klaus Engelke, Ph.D., BioClinica

Mike Espey, PhD, NCI

Josh Fessel, M.D., Ph.D., NCATS

Céline Fournier, Ph.D., Echosens

Christian Friedrich, Bayer

Gopi Ganji, Ph.D., GlaxoSmithKline

Chelsea Gordon, MBA, Verily

Chris Hartshorn, PhD, NCI

Claude Hughes, M.D., Ph.D., IQVIA

Lyndon Joseph, Ph.D., NIH/NIA

Satya Karnik, Ph.D., Regeneron

Morten Karsdal, Ph.D., M.Sc., mMBA, Nordic Bioscience A/S

Helina Kassahun, M.D., Amgen

Keith Kaufman, M.D., Merck

Young S. Kim, Ph.D., NIH/NCI

Kathy Landschulz, Ph.D., Covance

Olof Dahlqvist Leinhard, Ph.D., AMRA Medical

Maria Chiara Magnone, Ph.D., Janssen

Mark Messenbaugh, JD, Somalogic

Mike Montalto, Ph.D., PathAI

Antonella Napolitano, M.D., Ph.D., GlaxoSmithKline

Afshin Parsa, M.D., MPH, NIH/NIDDK

Ketan Patel, D. Phil., Clarivate

Malhar Patel, M.D., Rhino Health

Aaron Pawlyk, PhD, NCHID

Sven Reimann, Ph.D., Bayer

Jim Revkin, M.D., Ph.D., Pfizer

James Rickard, M.Pharm, Richmond Research Institute

Anthony Samir M.D., MGH

Arun Sanyal, M.D., VCU

Sudha Shankar, M.D., AstraZeneca

Gad Soffer, General Metabolics

Pothur Srinivas, Ph.D., NIH/NHLBI

Elizabeth Stafford, Ph.D., FDA/CDRH

Paresh Thakker, Ph.D., Takeda

Melissa Thomas, M.D., Ph.D., Eli Lilly

Moises Torres-Gonzalez, Ph.D., National Dairy Council

Sharat Varma, Ph.D., Novo Nordisk

Megann Vaughn, M.B.A., LabCorp

David R. Vera, Ph.D., University of California, San Diego

Tony Wagner, PhD, Jazz Pharmaceuticals

Sean Walsh, Ph.D., Radiomics

Mike Ward, Ph.D., Alector

Joel Wommack, Ph.D., SomaLogic